International Cannabis Weekly: 393

FRANCE FINALLY UNVEILS LONG-AWAITED BLUEPRINT FOR FULL MEDICAL CANNABIS ROLLOUT

France’s four-year campaign to launch a fully regulated generalised medical cannabis framework is finally being realised, just weeks after thousands of participants in France’s medical cannabis ‘experiment’ prepared to wean themselves off treatment.

READ MORE  »

2 MORE SWISS ADULT-USE CANNABIS PILOT TRIALS COULD SOON BE APPROVED

READ MORE »

INTERACTIVE INTELLIGENCE HUB FOR THE EUROPEAN INDUSTRY LAUNCHING SOON

READ MORE »

• Celadon Pharmaceuticals is the latest major European publicly listed cannabis company to announce plans to de-list.
• A quarter of UK adults are still unaware that medical cannabis can be legally prescribed by the NHS.
• Italy’s hemp and CBD market is now generating €2 billion and currently employs 20,000 people.
• Australian pharma company Bioxyne secures investment for cultivation facilities in UK & Czech Republic.
• EUDA study shows a drop in cannabis traces in wastewater, however a rise in stimulants.
• Xebra Brands explores its strategic options after receiving Dutch cannabis licence.

PRE-REGISTER INTEREST »

• Virginia’s governor controversially vetoes adult-use cannabis legalisation for second consecutive year.
• New Hampshire Senate committee reviews several cannabis bills passed by the House.
• Tennessee lawmakers earmarked to consider new marijuana and hemp bills this week.
• Minnesota’s adult-use cannabis sales have moved closer as judge reviews draft rules.
• This is how US-China tariffs could have knock-on affects on the American cannabis industry.
• Outdoor cannabis cultivation could cut emissions by up to 76%, a new study finds.

• Cannabis stocks positioned for growth amid new North American regulatory shifts.
• Organigram rebrands to reflect its leadership in Canada and global cannabis markets.
• Aurora Cannabis has announced discovery of powdery mildew-resistant cultivars.
• MTL Cannabis Corp has announced OTCQB listing to reach new U.S. investors.
• Auxly has reported its full-year 2024 results, outlining financial challenges and outlook.
• Canadian cannabis flower prices are continuing to climb through February 2025.

• Anvisa debates changes to cannabis product regulations during latest Dicol meeting.
• Argentina’s INSAE and ARICCAME under fire for blocking cannabis trade—what’s next?
• Chilean lawmakers and 40+ groups call for end to cannabis criminalisation and clear rules.
• Paraguay prepares for the legal production of marijuana with the participation of 10,000 producers.

• Australia’s drug-driving rules for medical cannabis patients under scrutiny as state leaders urged to rethink. 
• Lyphe Australia’s GM joins Cannatrek to support its national cannabis expansion plans.
• University of South Australia develops new tech to improve the bioavailability of CBD.
• Stocktake raises $3M for its cannabis market push across Europe as part of expansion plans.

• South Africa reverses hemp food ban and pledges broader cannabis industry consultation.
• Botswana hosts a major hemp Indaba to chart a new regulatory landscape for growth.